Canada raises new jurisdictional objection in Eli Lilly NAFTA case, while investor stands by its judicial expropriation and FET claims

You are not logged in. If you are a subscriber, please Login to access. If you are not a subscriber, you can contact us for a rate quote at Alternatively, you can sign up to receive free email headlines here.